Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 453 participants.

Also called NCT01918215

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 453 participants (enrolled count) (from the registry)
Sponsor
Flinders University (from the registry)
Registry
  • NCT NCT01918215
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Germany, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01918215. Randomized; no masking; primary purpose prevention. Start 2015-07 (actual); primary completion 2026-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
Acronym
CMR_GUIDE
Condition
Heart Failure
Condition
Left Ventricular Systolic Dysfunction
Intervention (Device)
ICD
Intervention (Device)
ILR
Lead sponsor
Flinders University (class: other)
Collaborator
South Australian Health and Medical Research Institute (class: other)

Record details

Record id
cardio:ct-nct01918215
Content hash
a59cfe48678ac002947fcd9eb5f591f5d498f32a92d0a842cb05b2a4074871a4